Prefilled Syringes Market by Material (Glass-based and Plastic-based), Design (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes), Therapeutics (Large Molecules and Small Molecules), and Application (Anaphylaxis, Rheumatoid Arthritis, Diabetes [Cancer, Multiple Sclerosis, and Others]) - Global Opportunity Analysis and Industry Forecast, 2017-2023
A “prefilled syringe” is a packet of vaccines which have a single and fixed quantity of dosage. Prefilled syringes are novel devices used for delivering drugs with improved efficacy, convenience, accuracy, affordability, sterility, safety and accessibility. These features make it more advantageous than traditional methods of drug delivery. Previously, glass or metal syringes were used. This involved keeping the drug-especially vaccines- in a vial, making it contagious or prone to contamination and increasing the possibility of dosing errors. Prefilled syringes eliminate the drawbacks mentioned above, which leads to an increase in their demand. The goal of this report is to offer thorough analysis of the segments related to the prefilled syringes market and a comprehensive analysis of the global market. The report also focuses on the current market size and potential growth of the prefilled syringes market in the future.
Prefilled syringes are gaining acceptance in the market as drug delivery systems designed for injectable drugs. They are generally preferred for parenteral administration of various drugs and are used mainly for the treatment of chronic diseases where patients have to administer medication themselves, several times a week. The key drivers for the growth of this market are rising incidences of chronic diseases that require frequent drug administration, growing home-based healthcare market, increasing adoption of injectable drugs, benefits over syringe packaging systems and growing demand for point-of-care drug administration. The major restraints for this market are the presence of alternative drug delivery means, the cost associated with the manufacturing of prefilled syringes, storage problem for these syringes and stringent regulations set by government authorities. Prefilled syringes offer several advantages over conventional vials to healthcare providers, drug manufacturers and patients such as accurate dosing, simple operation and lower risk of contamination. Moreover, technological advancement, new innovations and meeting the unmet demand for these syringes are the key opportunities for the foreseeable future of the prefilled syringes market.
Prefilled Syringes Market Analysis by Types
On the basis of types, the global prefilled syringes market is segmented into glass-based prefilled syringes and plastic-based prefilled syringes. Glass-based prefilled syringes accounted for the largest share (about 90% in 2012) in terms of both volume and revenue. This is due to glass being the preferred material owing to properties such as robustness, transparency, tolerability, strength, chemical inertness and its non-reactive nature. However, plastic-based prefilled syringes are expected to grow at a faster CAGR during the forecast period 2013-2020 due to the recent development of polymer technology based plastics used to manufacture prefilled syringes.
Prefilled Syringes Market Analysis by Application
The prefilled syringes market can be segmented on the basis of applications into insulin, MAbs, Erythropoietin, G-CSF agents, interferon, vaccines and others. Vaccines and insulin hold the highest market share in the prefilled syringes market due to rising incidences of chronic diseases such as diabetes, which requires insulin administration on a daily basis.
Prefilled Syringes Market Analysis by Geography
The key geographical areas analyzed in the report are North America, Europe, Asia pacific and LAMEA. Europe holds the largest market share in the prefilled syringes market due to the high rate of adoption in this region. The North American market is also forecast to grow at a high CAGR due to prefilled syringes being the most preferred devices for drug delivery and the rising demand from the patients who need home-based healthcare treatment.
Competitive Analysis
The key companies profiled in this report are Becton, Dickinson & Company, Baxter International, Inc., Bespak, Nipro Corporation, Gerresheimer AG, Schott AG, Unilife Corporation, Stevanato Group, West Pharmaceutical Services, Inc., Vetter Pharma International GmbH and others. Technological advancement is the key strategy adopted by drug developers and drug packaging manufacturers.
High level analysis
The analysis provides an outline of the prefilled syringes market, its opportunities, drivers and key concerns. The different forces that are responsible for the prevailing market trends are explored using Porter’s Five Forces tool. According to Porter’s Five Forces analysis, the bargaining power of the supplier is high as products are highly differentiated. High switching cost leads to the low bargaining power of buyers. Threat of new entrants is low due to the stringent government polices and cost of manufacturing prefilled syringes.
KEY BENEFITS
The market is segmented into types, applications and regions as follows:
By types
Prefilled syringes are gaining acceptance in the market as drug delivery systems designed for injectable drugs. They are generally preferred for parenteral administration of various drugs and are used mainly for the treatment of chronic diseases where patients have to administer medication themselves, several times a week. The key drivers for the growth of this market are rising incidences of chronic diseases that require frequent drug administration, growing home-based healthcare market, increasing adoption of injectable drugs, benefits over syringe packaging systems and growing demand for point-of-care drug administration. The major restraints for this market are the presence of alternative drug delivery means, the cost associated with the manufacturing of prefilled syringes, storage problem for these syringes and stringent regulations set by government authorities. Prefilled syringes offer several advantages over conventional vials to healthcare providers, drug manufacturers and patients such as accurate dosing, simple operation and lower risk of contamination. Moreover, technological advancement, new innovations and meeting the unmet demand for these syringes are the key opportunities for the foreseeable future of the prefilled syringes market.
Prefilled Syringes Market Analysis by Types
On the basis of types, the global prefilled syringes market is segmented into glass-based prefilled syringes and plastic-based prefilled syringes. Glass-based prefilled syringes accounted for the largest share (about 90% in 2012) in terms of both volume and revenue. This is due to glass being the preferred material owing to properties such as robustness, transparency, tolerability, strength, chemical inertness and its non-reactive nature. However, plastic-based prefilled syringes are expected to grow at a faster CAGR during the forecast period 2013-2020 due to the recent development of polymer technology based plastics used to manufacture prefilled syringes.
Prefilled Syringes Market Analysis by Application
The prefilled syringes market can be segmented on the basis of applications into insulin, MAbs, Erythropoietin, G-CSF agents, interferon, vaccines and others. Vaccines and insulin hold the highest market share in the prefilled syringes market due to rising incidences of chronic diseases such as diabetes, which requires insulin administration on a daily basis.
Prefilled Syringes Market Analysis by Geography
The key geographical areas analyzed in the report are North America, Europe, Asia pacific and LAMEA. Europe holds the largest market share in the prefilled syringes market due to the high rate of adoption in this region. The North American market is also forecast to grow at a high CAGR due to prefilled syringes being the most preferred devices for drug delivery and the rising demand from the patients who need home-based healthcare treatment.
Competitive Analysis
The key companies profiled in this report are Becton, Dickinson & Company, Baxter International, Inc., Bespak, Nipro Corporation, Gerresheimer AG, Schott AG, Unilife Corporation, Stevanato Group, West Pharmaceutical Services, Inc., Vetter Pharma International GmbH and others. Technological advancement is the key strategy adopted by drug developers and drug packaging manufacturers.
High level analysis
The analysis provides an outline of the prefilled syringes market, its opportunities, drivers and key concerns. The different forces that are responsible for the prevailing market trends are explored using Porter’s Five Forces tool. According to Porter’s Five Forces analysis, the bargaining power of the supplier is high as products are highly differentiated. High switching cost leads to the low bargaining power of buyers. Threat of new entrants is low due to the stringent government polices and cost of manufacturing prefilled syringes.
KEY BENEFITS
- The analysis provides an overview of the factors driving and limiting the growth of the market, including market trends, market structure and others
- Market estimation for product type and geographic segments is derived from current market scenario and expected market trends
- Porter’s Five Force model and SWOT analysis are strategically discussed for the global prefilled syringe market, which would help in making strategic decisions
- The analysis assists in understanding the strategies adopted by the companies for the growth of this market
- In-depth analysis of the types of products used in the prefilled syringes market would help in identifying the future applications in this market
The market is segmented into types, applications and regions as follows:
By types
- Glass-based Prefilled Syringes
- Plastic-based Prefilled Syringes
- Insulin
- MAbs (Monoclonal antibodies)
- Erythropoietin
- G-CSF agents
- Interferon
- Vaccines
- Follow-on Proteins and Biosimilars
- Recombinant Coagulation Factors
- Other Therapeutic Proteins
- North America
- Europe
- Asia Pacific
- LAMEA
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Growth in home-based healthcare market
3.5.1.2. Increase in adoption of injectable drugs
3.5.1.3. Rise in incidence rate of chronic disease
3.5.1.4. Benefits of using prefilled syringes over conventional vials
3.5.1.5. Technological advancement
3.5.2. Restraints
3.5.2.1. Stringent government regulations
3.5.2.2. Availability of alternate drug-delivery methods
3.5.2.3. Product recalls
3.5.3. Opportunities
3.5.3.1. Rise in demand for biologics and biosimilars
3.5.3.2. Increase in demand for injectable drugs in prefilled forms
CHAPTER 4 PREFILLED SYRINGES MARKET, BY MATERIAL
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. GLASS-BASED PREFILLED SYRINGES
4.2.1. Market size and forecast
4.3. PLASTIC-BASED PREFILLED SYRINGES
4.3.1. Market size and forecast
CHAPTER 5 PREFILLED SYRINGES MARKET, BY DESIGN
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. SINGLE-CHAMBER PREFILLED SYRINGES
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.3. DUAL-CHAMBER PREFILLED SYRINGES
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.4. CUSTOMIZED PREFILLED SYRINGES
5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast
CHAPTER 6 PREFILLED SYRINGES MARKET, BY THERAPEUTICS
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. LARGE MOLECULES
6.2.1. Market size and forecast
6.3. SMALL MOLECULES
6.3.1. Market size and forecast
CHAPTER 7 PREFILLED SYRINGES MARKET, BY APPLICATION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. ANAPHYLAXIS
7.2.1. Market size and forecast
7.3. RHEUMATOID ARTHRITIS
7.3.1. Market size and forecast
7.4. DIABETES
7.4.1. Market size and forecast
7.5. OTHERS APPLICATIONS
7.5.1. Market size and forecast
CHAPTER 8 PREFILLED SYRINGES MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Mexico market size and forecast
8.2.3.3. Canada market size and forecast
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.3.1. UK market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. Germany market size and forecast
8.3.3.4. Rest of Europe market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.3.1. India market size and forecast
8.4.3.2. Japan market size and forecast
8.4.3.3. China market size and forecast
8.4.3.4. Rest of Asia-Pacific market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. South Africa market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. BECTON, DICKINSON AND COMPANY
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments
9.2. MEDTRONIC PLC
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments
9.3. GERRESHEIMER AG
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. TERUMO MEDICAL CORPORATION
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. WEST PHARMACEUTICAL SERVICES, INC.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. NIPRO CORPORATION
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments
9.7. UNILIFE CORPORATION
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments
9.8. VETTER PHARMA INTERNATIONAL GMBH
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. BAXTER INTERNATIONAL
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. ABBOTT LABORATORIES
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Growth in home-based healthcare market
3.5.1.2. Increase in adoption of injectable drugs
3.5.1.3. Rise in incidence rate of chronic disease
3.5.1.4. Benefits of using prefilled syringes over conventional vials
3.5.1.5. Technological advancement
3.5.2. Restraints
3.5.2.1. Stringent government regulations
3.5.2.2. Availability of alternate drug-delivery methods
3.5.2.3. Product recalls
3.5.3. Opportunities
3.5.3.1. Rise in demand for biologics and biosimilars
3.5.3.2. Increase in demand for injectable drugs in prefilled forms
CHAPTER 4 PREFILLED SYRINGES MARKET, BY MATERIAL
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. GLASS-BASED PREFILLED SYRINGES
4.2.1. Market size and forecast
4.3. PLASTIC-BASED PREFILLED SYRINGES
4.3.1. Market size and forecast
CHAPTER 5 PREFILLED SYRINGES MARKET, BY DESIGN
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. SINGLE-CHAMBER PREFILLED SYRINGES
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.3. DUAL-CHAMBER PREFILLED SYRINGES
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.4. CUSTOMIZED PREFILLED SYRINGES
5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast
CHAPTER 6 PREFILLED SYRINGES MARKET, BY THERAPEUTICS
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. LARGE MOLECULES
6.2.1. Market size and forecast
6.3. SMALL MOLECULES
6.3.1. Market size and forecast
CHAPTER 7 PREFILLED SYRINGES MARKET, BY APPLICATION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. ANAPHYLAXIS
7.2.1. Market size and forecast
7.3. RHEUMATOID ARTHRITIS
7.3.1. Market size and forecast
7.4. DIABETES
7.4.1. Market size and forecast
7.5. OTHERS APPLICATIONS
7.5.1. Market size and forecast
CHAPTER 8 PREFILLED SYRINGES MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Mexico market size and forecast
8.2.3.3. Canada market size and forecast
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.3.1. UK market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. Germany market size and forecast
8.3.3.4. Rest of Europe market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.3.1. India market size and forecast
8.4.3.2. Japan market size and forecast
8.4.3.3. China market size and forecast
8.4.3.4. Rest of Asia-Pacific market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. South Africa market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. BECTON, DICKINSON AND COMPANY
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments
9.2. MEDTRONIC PLC
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments
9.3. GERRESHEIMER AG
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. TERUMO MEDICAL CORPORATION
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. WEST PHARMACEUTICAL SERVICES, INC.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. NIPRO CORPORATION
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments
9.7. UNILIFE CORPORATION
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments
9.8. VETTER PHARMA INTERNATIONAL GMBH
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. BAXTER INTERNATIONAL
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. ABBOTT LABORATORIES
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 2. GLASS-BASED PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. PLASTIC-BASED PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 5. SINGLE-CHAMBER PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. DUAL-CHAMBER PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. CUSTOMIZED PREFILLED SYRINGES, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 9. PREFILLED SYRINGES MARKET FOR LARGE MOLECULES, BY REGION, 2016-2023 ($MILLION)
TABLE 10. PREFILLED SYRINGES MARKET FOR SMALL MOLECULES, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 12. PREFILLED SYRINGES MARKET FOR ANAPHYLAXIS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. PREFILLED SYRINGES MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. PREFILLED SYRINGES MARKET FOR DIABETES, BY REGION, 2016-2023 ($MILLION)
TABLE 15. PREFILLED SYRINGES MARKET FOR OTHER APPLICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 16. PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA PREFILLED SYRINGES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 22. EUROPE PREFILLED SYRINGES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23. EUROPE PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 24. EUROPE PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 25. EUROPE PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 26. EUROPE PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 27. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 29. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 32. LAMEA PREFILLED SYRINGES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 33. LAMEA PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 34. LAMEA PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 35. LAMEA PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 36. LAMEA PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 37. BD: COMPANY SNAPSHOT
TABLE 38. BD: OPERATING SEGMENTS
TABLE 39. MEDTRONIC: COMPANY SNAPSHOT
TABLE 40. MEDTRONIC: OPERATING SEGMENTS
TABLE 41. GERRESHEIMER: COMPANY SNAPSHOT
TABLE 42. GERRESHEIMER: OPERATING SEGMENTS
TABLE 43. TERUMO: COMPANY SNAPSHOT
TABLE 44. TERUMO: OPERATING SEGMENTS
TABLE 45. WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
TABLE 46. WEST PHARMACEUTICAL SERVICES: OPERATING SEGMENTS
TABLE 47. NIPRO: COMPANY SNAPSHOT
TABLE 48. NIPRO: OPERATING SEGMENTS
TABLE 49. UNILIFE: COMPANY SNAPSHOT
TABLE 50. UNILIFE: OPERATING SEGMENTS
TABLE 51. VETTER: COMPANY SNAPSHOT
TABLE 52. VETTER: OPERATING SEGMENTS
TABLE 53. BAXTER: COMPANY SNAPSHOT
TABLE 54. BAXTER: OPERATING SEGMENTS
TABLE 55. ABBOTT: COMPANY SNAPSHOT
TABLE 56. ABBOTT: OPERATING SEGMENTS
TABLE 1. GLOBAL PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 2. GLASS-BASED PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. PLASTIC-BASED PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 5. SINGLE-CHAMBER PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. DUAL-CHAMBER PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. CUSTOMIZED PREFILLED SYRINGES, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 9. PREFILLED SYRINGES MARKET FOR LARGE MOLECULES, BY REGION, 2016-2023 ($MILLION)
TABLE 10. PREFILLED SYRINGES MARKET FOR SMALL MOLECULES, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 12. PREFILLED SYRINGES MARKET FOR ANAPHYLAXIS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. PREFILLED SYRINGES MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. PREFILLED SYRINGES MARKET FOR DIABETES, BY REGION, 2016-2023 ($MILLION)
TABLE 15. PREFILLED SYRINGES MARKET FOR OTHER APPLICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 16. PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA PREFILLED SYRINGES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 22. EUROPE PREFILLED SYRINGES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23. EUROPE PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 24. EUROPE PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 25. EUROPE PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 26. EUROPE PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 27. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 29. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 32. LAMEA PREFILLED SYRINGES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 33. LAMEA PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 34. LAMEA PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 35. LAMEA PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 36. LAMEA PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 37. BD: COMPANY SNAPSHOT
TABLE 38. BD: OPERATING SEGMENTS
TABLE 39. MEDTRONIC: COMPANY SNAPSHOT
TABLE 40. MEDTRONIC: OPERATING SEGMENTS
TABLE 41. GERRESHEIMER: COMPANY SNAPSHOT
TABLE 42. GERRESHEIMER: OPERATING SEGMENTS
TABLE 43. TERUMO: COMPANY SNAPSHOT
TABLE 44. TERUMO: OPERATING SEGMENTS
TABLE 45. WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
TABLE 46. WEST PHARMACEUTICAL SERVICES: OPERATING SEGMENTS
TABLE 47. NIPRO: COMPANY SNAPSHOT
TABLE 48. NIPRO: OPERATING SEGMENTS
TABLE 49. UNILIFE: COMPANY SNAPSHOT
TABLE 50. UNILIFE: OPERATING SEGMENTS
TABLE 51. VETTER: COMPANY SNAPSHOT
TABLE 52. VETTER: OPERATING SEGMENTS
TABLE 53. BAXTER: COMPANY SNAPSHOT
TABLE 54. BAXTER: OPERATING SEGMENTS
TABLE 55. ABBOTT: COMPANY SNAPSHOT
TABLE 56. ABBOTT: OPERATING SEGMENTS
LIST OF FIGURES
FIGURE 1. SEGMENTATION OF GLOBAL PREFILLED SYRINGES MARKET
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL PREFILLED SYRINGES MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 6. BARGAINING POWER OF BUYERS
FIGURE 7. BARGAINING POWER OF SUPPLIERS
FIGURE 8. THREAT OF NEW ENTRANTS
FIGURE 9. THREAT OF SUBSTITUTION
FIGURE 10. COMPETITIVE RIVALRY
FIGURE 11. RESTRAINTS AND DRIVERS: GLOBAL PREFILLED SYRINGES MARKET
FIGURE 12. GLOBAL PREFILLED SYRINGES MARKET: SEGMENTATION BY MATERIAL
FIGURE 13. GLOBAL PREFILLED SYRINGES MARKET: SEGMENTATION BY DESIGN
FIGURE 14. GLOBAL PREFILLED SYRINGES MARKET: SEGMENTATION BY THERAPEUTICS
FIGURE 15. GLOBAL PREFILLED SYRINGES MARKET: SEGMENTATION BY APPLICATION
FIGURE 16. U.S. PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 17. MEXICO PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 18. CANADA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 19. UK PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 20. FRANCE PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 21. GERMANY PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 22. REST OF EUROPE PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 23. INDIA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 24. JAPAN PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 25. CHINA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 27. BRAZIL PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 28. SOUTH AFRICA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 29. SAUDI ARABIA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 30. REST OF LAMEA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 1. SEGMENTATION OF GLOBAL PREFILLED SYRINGES MARKET
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL PREFILLED SYRINGES MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 6. BARGAINING POWER OF BUYERS
FIGURE 7. BARGAINING POWER OF SUPPLIERS
FIGURE 8. THREAT OF NEW ENTRANTS
FIGURE 9. THREAT OF SUBSTITUTION
FIGURE 10. COMPETITIVE RIVALRY
FIGURE 11. RESTRAINTS AND DRIVERS: GLOBAL PREFILLED SYRINGES MARKET
FIGURE 12. GLOBAL PREFILLED SYRINGES MARKET: SEGMENTATION BY MATERIAL
FIGURE 13. GLOBAL PREFILLED SYRINGES MARKET: SEGMENTATION BY DESIGN
FIGURE 14. GLOBAL PREFILLED SYRINGES MARKET: SEGMENTATION BY THERAPEUTICS
FIGURE 15. GLOBAL PREFILLED SYRINGES MARKET: SEGMENTATION BY APPLICATION
FIGURE 16. U.S. PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 17. MEXICO PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 18. CANADA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 19. UK PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 20. FRANCE PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 21. GERMANY PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 22. REST OF EUROPE PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 23. INDIA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 24. JAPAN PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 25. CHINA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 27. BRAZIL PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 28. SOUTH AFRICA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 29. SAUDI ARABIA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 30. REST OF LAMEA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
